Ablative margins in percutaneous thermal ablation of hepatic tumors: a systematic review

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi: 10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• de Ridder J, de Wilt JH, Simmer F, et al. Incidence and origin of histologically confirmed liver metastases: an explorative case-study of 23,154 patients. Oncotarget. 2016;7(34):55368–55376. doi: 10.18632/oncotarget.10552
   PubMedGoogle Scholar
• Hugen N, van de Velde CJH, de Wilt JHW, et al. Metastatic pattern in colorectal cancer is strongly influenced by histological subtype. Ann Oncol. 2014;25(3):651–657. doi: 10.1093/annonc/mdt591
   PubMed Web of Science ®Google Scholar
• Riihimaki M, Thomsen H, Sundquist K, et al. Clinical landscape of cancer metastases. Cancer Med. 2018;7(11):5534–5542. doi:10.1002/cam4.1697
   PubMed Web of Science ®Google Scholar
• Engstrand J, Nilsson H, Stromberg C, et al. Colorectal cancer liver metastases - a population-based study on incidence, management and survival. BMC Cancer. 2018;18(1):78. doi: 10.1186/s12885-017-3925-x
   PubMed Web of Science ®Google Scholar
• van der Geest LG, Lam-Boer J, Koopman M, et al. Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases. Clin Exp Metastasis. 2015;32(5):457–465. doi: 10.1007/s10585-015-9719-0
   PubMed Web of Science ®Google Scholar
• Qaderi SM, Galjart B, Verhoef C, et al. Disease recurrence after colorectal cancer surgery in the modern era: a population-based study. Int J Colorectal Dis. 2021;36(11):2399–2410. doi: 10.1007/s00384-021-03914-w
   PubMed Web of Science ®Google Scholar
• Ding J, Wen Z. Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database. BMC Cancer. 2021;21(1):1157. doi: 10.1186/s12885-021-08904-3
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi: 10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Brar G, Greten TF, Graubard BI, et al. Hepatocellular carcinoma survival by Etiology: a SEER-Medicare database analysis. Hepatol Commun. 2020;4(10):1541–1551. doi: 10.1002/hep4.1564
   PubMed Web of Science ®Google Scholar
• Petrowsky H, Fritsch R, Guckenberger M, et al. Modern therapeutic approaches for the treatment of malignant liver tumours. Nat Rev Gastroenterol Hepatol. 2020;17(12):755–772. doi: 10.1038/s41575-020-0314-8
   PubMed Web of Science ®Google Scholar
• de Ridder JA, Lemmens VE, Overbeek LI, et al. Liver resection for metastatic disease; a population-based analysis of trends. Dig Surg. 2016;33(2):104–113. doi: 10.1159/000441802
   PubMed Web of Science ®Google Scholar
• Glassberg MB, Ghosh S, Clymer JW, et al. Microwave ablation compared with hepatic resection for the treatment of hepatocellular carcinoma and liver metastases: a systematic review and meta-analysis. World J Surg Oncol. 2019;17(1):98. doi: 10.1186/s12957-019-1632-6
   PubMed Web of Science ®Google Scholar
• Yang G, Xiong Y, Sun J, et al. The efficacy of microwave ablation versus liver resection in the treatment of hepatocellular carcinoma and liver metastases: a systematic review and meta-analysis. Int J Surg. 2020;77:85–93. doi: 10.1016/j.ijsu.2020.03.006
   PubMed Web of Science ®Google Scholar
• Dijkstra M, Nieuwenhuizen S, Puijk RS, et al. Thermal ablation compared to partial hepatectomy for recurrent colorectal liver metastases: an Amsterdam Colorectal liver met Registry (AmCORE) based study. Cancers (Basel). 2021;13(11):2769. doi: 10.3390/cancers13112769
   PubMed Web of Science ®Google Scholar
• van Amerongen MJ, Jenniskens SFM, van den Boezem PB, et al. Radiofrequency ablation compared to surgical resection for curative treatment of patients with colorectal liver metastases - a meta-analysis. HPB (Oxford). 2017;19(9):749–756. doi: 10.1016/j.hpb.2017.05.011
   PubMed Web of Science ®Google Scholar
• van Amerongen MJ, van der Stok EP, Futterer JJ, et al. Results after simultaneous surgery and RFA liver ablation for patients with colorectal carcinoma and synchronous liver metastases. Eur J Surg Oncol. 2019;45(12):2334–2339. doi: 10.1016/j.ejso.2019.07.016
   PubMed Web of Science ®Google Scholar
• Garuti F, Neri A, Avanzato F, et al. The changing scenario of hepatocellular carcinoma in Italy: an update. Liver Int. 2021;41(3):585–597. doi: 10.1111/liv.14735
   PubMed Web of Science ®Google Scholar
• Reinders MTM, van Meer S, Burgmans MC, et al. Trends in incidence, diagnosis, treatment and survival of hepatocellular carcinoma in a low-incidence country: data from the Netherlands in the period 2009-2016. Eur J Cancer. 2020;137:214–223. doi: 10.1016/j.ejca.2020.07.008
   PubMed Web of Science ®Google Scholar
• Takahashi H, Kahramangil B, Berber E. Local recurrence after microwave thermosphere ablation of malignant liver tumors: results of a surgical series. Surgery. 2018;163(4):709–713. doi: 10.1016/j.surg.2017.10.026
   PubMed Web of Science ®Google Scholar
• Kingham TP, Tanoue M, Eaton A, et al. Patterns of recurrence after ablation of colorectal cancer liver metastases. Ann Surg Oncol. 2012;19(3):834–841. doi: 10.1245/s10434-011-2048-x
   PubMed Web of Science ®Google Scholar
• Leung U, Kuk D, D’Angelica MI, et al. Long-term outcomes following microwave ablation for liver malignancies. Br J Surg. 2015;102(1):85–91. doi: 10.1002/bjs.9649
   PubMed Web of Science ®Google Scholar
• Schullian P, Laimer G, Johnston E, et al. Technical efficacy and local recurrence after stereotactic radiofrequency ablation of 2653 liver tumors: a 15-year single-center experience with evaluation of prognostic factors. Int J Hyperthermia. 2022;39(1):421–430. doi: 10.1080/02656736.2022.2044522
   PubMed Web of Science ®Google Scholar
• Shi Y, Wang Z, Chi J, et al. Long-term results of percutaneous microwave ablation for colorectal liver metastases. HPB (Oxford). 2021;23(1):37–45. doi: 10.1016/j.hpb.2020.04.007
   PubMed Web of Science ®Google Scholar
• Jiang B, Luo H, Yan K, et al. Ten-year outcomes of percutaneous radiofrequency ablation for colorectal cancer liver metastases in perivascular vs. Non-perivascular locations: a propensity-score matched study. Front Oncol. 2020;10:553556. doi: 10.3389/fonc.2020.553556
   PubMed Web of Science ®Google Scholar
• Mulier S, Ni Y, Jamart J, et al. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg. 2005;242(2):158–171. doi:10.1097/01.sla.0000171032.99149.fe
   PubMed Web of Science ®Google Scholar
• Sibinga Mulder BG, Hendriks P, Baetens TR, et al. Quantitative margin assessment of radiofrequency ablation of a solitary colorectal hepatic metastasis using MIRADA RTx on CT scans: a feasibility study. BMC Med Imaging. 2019;19(1):71. doi: 10.1186/s12880-019-0360-2
   PubMed Web of Science ®Google Scholar
• Wells SA, Hinshaw JL, Lubner MG, et al. Liver ablation: best practice. Radiol Clin North Am. 2015;53(5):933–971. doi: 10.1016/j.rcl.2015.05.012
   PubMed Web of Science ®Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71
   PubMed Web of Science ®Google Scholar
• Kwon Y, Lemieux M, McTavish J, et al. Identifying and removing duplicate records from systematic review searches. J Med Libr Assoc. 2015;103(4):184–188. doi: 10.3163/1536-5050.103.4.004
   PubMed Web of Science ®Google Scholar
• Clark J, Glasziou P, Del Mar C, et al. A full systematic review was completed in 2 weeks using automation tools: a case study. J Clin Epidemiol. 2020;121:81–90. doi: 10.1016/j.jclinepi.2020.01.008
   PubMed Web of Science ®Google Scholar
• Wells G, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2022. https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
   Google Scholar
• An C, Jiang Y, Huang Z, et al. Assessment of ablative margin after microwave ablation for hepatocellular carcinoma using deep learning-based deformable image registration. Front Oncol. 2020;10:573316. doi: 10.3389/fonc.2020.573316
   PubMed Web of Science ®Google Scholar
• An C, Li X, Liang P, et al. A tumor map generated from three-dimensional visualization of image fusion for the assessment of microwave ablation of hepatocellular carcinoma: a preliminary study. Cancer Manag Res. 2019;11:1569–1578. doi: 10.2147/CMAR.S195354
   PubMed Web of Science ®Google Scholar
• Bo XW, Xu HX, Guo LH, et al. Ablative safety margin depicted by fusion imaging with post-treatment contrast-enhanced ultrasound and pre-treatment CECT/CEMRI after radiofrequency ablation for liver cancers. Br J Radiol. 2017;90(1078):20170063. doi: 10.1259/bjr.20170063
   PubMed Web of Science ®Google Scholar
• Du H, Tan X, Cheng L, et al. Application and evaluation of a 64-slice CT three-dimensional fusion technique in the determination of the effective ablation margin after radiofrequency ablation of hepatocellular carcinoma. Comput Math Methods Med. 2022;2022:1–12. doi: 10.1155/2022/6898233
   Web of Science ®Google Scholar
• Faber RA, Burghout KST, Bijlstra OD, et al. Three-dimensional quantitative margin assessment in patients with colorectal liver metastases treated with percutaneous thermal ablation using semi-automatic rigid MRI/CECT-CECT co-registration. Eur J Radiol. 2022;156:110552. doi: 10.1016/j.ejrad.2022.110552
   PubMed Web of Science ®Google Scholar
• Fukuda K, Mori K, Hasegawa N, et al. Safety margin of radiofrequency ablation for hepatocellular carcinoma: a prospective study using magnetic resonance imaging with superparamagnetic iron oxide. Jpn J Radiol. 2019;37(7):555–563. doi: 10.1007/s11604-019-00843-1
   PubMed Web of Science ®Google Scholar
• Hendriks P, Noortman WA, Baetens TR, et al. Quantitative volumetric assessment of ablative margins in hepatocellular carcinoma: predicting local tumor progression using nonrigid registration software. J Oncol. 2019;2019:1–8. doi: 10.1155/2019/4049287
   Web of Science ®Google Scholar
• Hocquelet A, Trillaud H, Frulio N, et al. Three-dimensional measurement of hepatocellular carcinoma ablation zones and margins for predicting local tumor progression. J Vasc Interv Radiol. 2017;27(7):1038–1045.e2. doi: 10.1016/j.jvir.2016.02.031
   Web of Science ®Google Scholar
• Inoue T, Kudo M, Hatanaka K, et al. Usefulness of contrast-enhanced ultrasonography to evaluate the post-treatment responses of radiofrequency ablation for hepatocellular carcinoma: comparison with dynamic CT. Oncology. 2013;84(Suppl 1):51–57. doi: 10.1159/000345890
   PubMed Web of Science ®Google Scholar
• Izaaryene J, Drai M, Deniel C, et al. Computed tomography-guided microwave ablation of perivascular liver metastases from colorectal cancer: a study of the ablation zone, feasibility, and safety. Int J Hyperthermia. 2021;38(1):887–899. doi: 10.1080/02656736.2021.1912413
   PubMed Web of Science ®Google Scholar
• Jiang C, Liu B, Chen S, et al. Safety margin after radiofrequency ablation of hepatocellular carcinoma: precise assessment with a three-dimensional reconstruction technique using CT imaging. Int J Hyperthermia. 2018;34(8):1135–1141. doi:10.1080/02656736.2017.1411981
   PubMed Web of Science ®Google Scholar
• Joo I, Morrow K, Raman S, et al. CT-monitored minimal ablative margin control in single-session microwave ablation of liver tumors: an effective strategy for local tumor control. Eur Radiol. 2022;32(9):6327–6335. doi: 10.1007/s00330-022-08723-5
   PubMed Web of Science ®Google Scholar
• Kaye EA, Cornelis FH, Petre EN, et al. Volumetric 3D assessment of ablation zones after thermal ablation of colorectal liver metastases to improve prediction of local tumor progression. Eur Radiol. 2019;29(5):2698–2705. doi: 10.1007/s00330-018-5809-0
   PubMed Web of Science ®Google Scholar
• Ke S, Ding X, Qian X, et al. Radiofrequency ablation of hepatocellular carcinoma sized > 3 and ≤ 5 cm: is ablative margin of more than 1 cm justified? World J Gastroenterol. 2014;19(42):7389. doi: 10.3748/wjg.v19.i42.7389
   Web of Science ®Google Scholar
• Kim S, Shin S, Lee B, et al. Imaging evaluation of ablative margin and index tumor immediately after radiofrequency ablation for hepatocellular carcinoma: comparison between multidetector-row CT and MR imaging. Abdom Radiol (NY). 2018;42(10):2527–2537. doi: 10.1007/s00261-017-1146-z
   Web of Science ®Google Scholar
• Laimer G, Jaschke N, Schullian P, et al. Volumetric assessment of the periablational safety margin after thermal ablation of colorectal liver metastases. Eur Radiol. 2021;31(9):6489–6499. doi: 10.1007/s00330-020-07579-x
   PubMed Web of Science ®Google Scholar
• Laimer G, Schullian P, Jaschke N, et al. Minimal ablative margin (MAM) assessment with image fusion: an independent predictor for local tumor progression in hepatocellular carcinoma after stereotactic radiofrequency ablation. Eur Radiol. 2020;30(5):2463–2472. doi: 10.1007/s00330-019-06609-7
   PubMed Web of Science ®Google Scholar
• Li FY, Li JG, Wu SS, et al. An optimal ablative margin of Small single hepatocellular carcinoma treated with image-guided percutaneous thermal ablation and local recurrence Prediction Base on the ablative margin: A multicenter study. J Hepatocell Carcinoma. 2021;8:1375–1388. doi: 10.2147/JHC.S330746
   PubMed Web of Science ®Google Scholar
• Li K, Su ZZ, Xu EJ, et al. Improvement of ablative margins by the intraoperative use of CEUS-CT/MR image fusion in hepatocellular carcinoma. BMC Cancer. 2016;16(1):277. doi: 10.1186/s12885-016-2306-1
   PubMed Web of Science ®Google Scholar
• Makino Y, Imai Y, Igura T, et al. Utility of computed tomography fusion imaging for the evaluation of the ablative margin of radiofrequency ablation for hepatocellular carcinoma and the correlation to local tumor progression. Hepatol Res. 2013;43(9):950–958. (Ed.^(Eds). doi: 10.1111/hepr.12049
   PubMed Web of Science ®Google Scholar
• Makino Y, Imai Y, Igura T, et al. Feasibility of extracted-overlay fusion imaging for intraoperative treatment evaluation of radiofrequency ablation for hepatocellular carcinoma. Liver Cancer. 2016;5(4):269–279. doi: 10.1159/000449338
   PubMed Web of Science ®Google Scholar
• Matsuki Y, Matono T, Koda M, et al. Preablation three-dimensional ultrasonography can predict therapeutic effect and local tumor progression after radiofrequency ablation for hepatocellular carcinoma. Eur J Radiol. 2021;133:109358. doi: 10.1016/j.ejrad.2020.109358
   Web of Science ®Google Scholar
• Minami Y, Minami T, Takita M, et al. Radiofrequency ablation for hepatocellular carcinoma: clinical value of ultrasound-ultrasound overlay fusion for optimal ablation and local controllability. Hepatol Res. 2020;50(1):67–74. doi: 10.1111/hepr.13407
   PubMed Web of Science ®Google Scholar
• Park J, Lee J, Lee D, et al. Value of nonrigid registration of pre-procedure MR with post-procedure CT after radiofrequency ablation for hepatocellular carcinoma. Cardiovasc Intervent Radiol. 2018;40(6):873–883. doi: 10.1007/s00270-017-1571-y
   Web of Science ®Google Scholar
• Ruiter SJS, Tinguely P, Paolucci I, et al. 3D quantitative ablation margins for prediction of ablation site recurrence after stereotactic image-guided microwave ablation of colorectal liver metastases: a multicenter study. Front Oncol. 2021;11:757167. doi: 10.3389/fonc.2021.757167
   PubMed Web of Science ®Google Scholar
• Sakakibara M, Ohkawa K, Katayama K, et al. Three-dimensional registration of images obtained before and after radiofrequency ablation of hepatocellular carcinoma to assess treatment adequacy. Am J Roentgenol. 2014;202(5):W487–W495. doi: 10.2214/AJR.13.11384
   PubMed Web of Science ®Google Scholar
• Sanga K, Numata K, Nihonmatsu H, et al. Use of intra-procedural fusion imaging combining contrast-enhanced ultrasound using a perflubutane-based contrast agent and auto sweep three-dimensional ultrasound for guiding radiofrequency ablation and evaluating its efficacy in patients with hepatocellular carcinoma. Int J Hyperthermia. 2020;37(1):202–211. doi: 10.1080/02656736.2020.1729422
   PubMed Web of Science ®Google Scholar
• Shady W, Petre EN, Do KG, et al. Percutaneous microwave versus radiofrequency ablation of colorectal liver metastases: ablation with clear margins (A0) provides the best local tumor control. J Vasc Interv Radiol. 2018;29(2):268–275 e261. doi: 10.1016/j.jvir.2017.08.021
   PubMed Web of Science ®Google Scholar
• Shin S, Lee JM, Kim KW, et al. Postablation assessment using follow-up registration of CT images before and after radiofrequency ablation (RFA): prospective evaluation of midterm therapeutic results of RFA for hepatocellular carcinoma. Am J Roentgenol. 2014;203(1):70–77. doi: 10.2214/AJR.13.11709
   PubMed Web of Science ®Google Scholar
• Solbiati M, Muglia R, Goldberg SN, et al. A novel software platform for volumetric assessment of ablation completeness. Int J Hyperthermia. 2019;36(1):337–343. doi: 10.1080/02656736.2019.1569267
   PubMed Web of Science ®Google Scholar
• Sparchez Z, Mocan T, Hajjar NA, et al. Percutaneous ultrasound guided radiofrequency and microwave ablation in the treatment of hepatic metastases. A monocentric initial experience. Med Ultrason. 2019;21(3):217–224. doi: 10.11152/mu-1957
   PubMed Web of Science ®Google Scholar
• Takeyama N, Mizobuchi N, Sakaki M, et al. Evaluation of hepatocellular carcinoma ablative margins using fused pre- and post-ablation hepatobiliary phase images. Abdom Radiol (NY). 2019;44(3):923–935. doi: 10.1007/s00261-018-1800-0
   PubMed Web of Science ®Google Scholar
• Tang H, Tang Y, Hong J, et al. A measure to assess the ablative margin using 3D-CT image fusion after radiofrequency ablation of hepatocellular carcinoma. HPB (Oxford). 2015;17(4):318–325. doi: 10.1111/hpb.12352
   PubMed Web of Science ®Google Scholar
• Tokunaga S, Koda M, Matono T, et al. Assessment of ablative margin by MRI with ferucarbotran in radiofrequency ablation for liver cancer: comparison with enhanced CT. Br J Radiol. 2012;85(1014):745–752. doi: 10.1259/bjr/64518148
   PubMed Web of Science ®Google Scholar
• Toshikuni N, Matsue Y, Ozaki K, et al. An image fusion System for Estimating the therapeutic effects of radiofrequency ablation on hepatocellular carcinoma. Radiol Oncol. 2017;51(3):263–269. doi: 10.1515/raon-2017-0028
   PubMed Web of Science ®Google Scholar
• Vasiniotis Kamarinos N, Gonen M, Sotirchos V, et al. 3D margin assessment predicts local tumor progression after ablation of colorectal cancer liver metastases. Int J Hyperthermia. 2022;39(1):880–887. doi: 10.1080/02656736.2022.2055795
   PubMed Web of Science ®Google Scholar
• Wang X, Li K, Su Z, et al. Assessment of radiofrequency ablation margin by MRI-MRI image fusion in hepatocellular carcinoma. World J Gastroenterol. 2016;21(17):5345. doi: 10.3748/wjg.v21.i17.5345
   Web of Science ®Google Scholar
• Wang XD, Sofocleous CT, Erinjeri JP, et al. Margin size is an independent predictor of local tumor progression after ablation of colon cancer liver metastases. Cardiovasc Intervent Radiol. 2013;36(1):166–175. doi: 10.1007/s00270-012-0377-1
   PubMed Web of Science ®Google Scholar
• Ye J, Huang G, Zhang X, et al. Three-dimensional contrast-enhanced ultrasound fusion imaging predicts local tumor progression by evaluating ablative margin of radiofrequency ablation for hepatocellular carcinoma: a preliminary report. Int J Hyperthermia. 2019;36(1):55–64. doi: 10.1080/02656736.2018.1530460
   PubMed Web of Science ®Google Scholar
• Yoon J, Lee J, Klotz E, et al. Prediction of local tumor progression after radiofrequency ablation (RFA) of hepatocellular carcinoma by assessment of ablative margin using pre-RFA MRI and post-RFA CT registration. Korean J Radiol. 2019;19(6):1053–1065. doi: 10.3348/kjr.2018.19.6.1053
   Web of Science ®Google Scholar
• Zhang X, Huang G, Ye J, et al. 3-D contrast-enhanced ultrasound fusion imaging: A New technique to evaluate the ablative margin of radiofrequency ablation for hepatocellular carcinoma. Ultrasound Med Biol. 2019;45(8):1933–1943. doi: 10.1016/j.ultrasmedbio.2019.03.019
   PubMed Web of Science ®Google Scholar
• Zhong-Zhen S, Kai L, Rong-Qin Z, et al. A feasibility study for determining ablative margin with 3D-CEUS-CT/MR image fusion after radiofrequency ablation of hepatocellular carcinoma. Ultraschall der Medizin. 2013;33(7):E250–E255. doi: 10.1055/s-0032-1325466
   Google Scholar
• Tan W, Deng Q, Lin S, et al. Comparison of microwave ablation and radiofrequency ablation for hepatocellular carcinoma: a systematic review and meta-analysis. Int J Hyperthermia. 2019;36(1):264–272. doi: 10.1080/02656736.2018.1562571
   PubMed Web of Science ®Google Scholar
• Glassberg MB, Ghosh S, Clymer JW, et al. Microwave ablation compared with radiofrequency ablation for treatment of hepatocellular carcinoma and liver metastases: a systematic review and meta-analysis. Onco Targets Ther. 2019;12:6407–6438. doi: 10.2147/OTT.S204340
   PubMed Web of Science ®Google Scholar
• Facciorusso A, Abd El Aziz MA, Tartaglia N, et al. Microwave ablation versus radiofrequency ablation for treatment of hepatocellular carcinoma: a meta-analysis of randomized controlled trials. Cancers (Basel). 2020;12(12):3796. doi: 10.3390/cancers12123796
   PubMed Web of Science ®Google Scholar
• Kim C. Understanding the nuances of microwave ablation for more accurate post-treatment assessment. Future Oncol. 2018;14(17):1755–1764. doi: 10.2217/fon-2017-0736
   PubMed Web of Science ®Google Scholar
• Finlay IG, Meek D, Brunton F, et al. Growth rate of hepatic metastases in colorectal carcinoma. Br J Surg. 1988;75(7):641–644. doi: 10.1002/bjs.1800750707
   PubMed Web of Science ®Google Scholar
• Kubota K, Ina H, Okada Y, et al. Growth rate of primary single hepatocellular carcinoma: determining optimal screening interval with contrast enhanced computed tomography. Dig Dis Sci. 2003;48(3):581–586. doi: 10.1023/A:1022505203786
   PubMed Web of Science ®Google Scholar
• Taouli B, Goh JS, Lu Y, et al. Growth rate of hepatocellular carcinoma: evaluation with serial computed tomography or magnetic resonance imaging. J Comput Assist Tomogr. 2005;29(4):425–429. doi: 10.1097/01.rct.0000164036.85327.05
   PubMed Web of Science ®Google Scholar
• Yu MH, Kim YJ, Park HS, et al. Shrinkage of hepatocellular carcinoma after radiofrequency ablation following transcatheter arterial chemoembolization: analysis of contributing factors. Plos One. 2019;14(2):e0210667. doi: 10.1371/journal.pone.0210667
   PubMed Web of Science ®Google Scholar
• Farina L, Weiss N, Nissenbaum Y, et al. Characterisation of tissue shrinkage during microwave thermal ablation. Int J Hyperthermia. 2014;30(7):419–428. doi: 10.3109/02656736.2014.957250
   PubMed Web of Science ®Google Scholar
• Schaible J, Pregler B, Bäumler W, et al. Safety margin assessment after microwave ablation of liver tumors: inter- and intrareader variability. Radiol Oncol. 2021;54(1):57–61. doi: 10.2478/raon-2020-0004
   Web of Science ®Google Scholar
• Zhou H, Yang G, Jing X, et al. Predictive value of ablative margin assessment after microwave ablation for local tumor progression in medium and large hepatocellular carcinoma: computed tomography–computed tomography image fusion method versus side-by-side method. J Comput Assist Tomogr. 2023;47(1):31–37. doi: 10.1097/RCT.0000000000001395
   PubMed Web of Science ®Google Scholar